US OptionsDetailed Quotes

VKTX250110C41000

Watchlist

0.08
0.000.00%

15min DelayTrading Jan 10 16:00 ET

0.00High0.00Low

Viking Therapeutics Stock Discussion

Justin Teeburd

4 hours ago

$Viking Therapeutics (VKTX.US)$

10xStockPicks

6 hours ago

Today 3 Analysts Place BUY Ratings On This $2 Stock $7,$9 & $16 Which Is An Acquisition Target by BIG Pharma

$Esperion Therapeutics (ESPR.US)$ Jan 23, 2025 Three analysts are bullish on Esperion Therapeutics with price targets on this $2 stock ranging from $7 to $16 a share.
Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...